TCM Biotech International Corp. engages in the research, development, manufacturing and sale of medicines, medical devices and functional food. Its products include medicines for osteoporosis, iron drops, antiviral tablets, urinary system treatment tablets, urosan capsules, expectorant, antineoplastics agents, anti-hypertensive tablets, spironolactone tablets, anti-diabetic tablets, uformin tablets, glusafe tablets and medical equipment. The company was founded on February 20, 1998 and is headquartered in New Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company